Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
about
Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres.Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.Surfactant-free formulation of poly(lactic/glycolic) acid nanoparticles encapsulating functional polypeptide: a technical note.Preparation and properties of BSA-loaded microspheres based on multi-(amino acid) copolymer for protein deliveryCalcium alginate/dextran methacrylate IPN beads as protecting carriers for protein delivery.In-situ formation of growth-factor-loaded coacervate microparticle-embedded hydrogels for directing encapsulated stem cell fate.Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration.Factors of importance for a successful delivery system for proteins.Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs.Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.Growth Factor-Loaded Microparticles for Tissue Engineering: The Discrepancies of In Vitro Characterization AssaysBiologically inspired approaches to drug delivery for nerve regeneration.Development of dextran nanoparticles for stabilizing delicate proteinsOral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advancesAssembly of protein-based hollow spheres encapsulating a therapeutic factorCell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.Designing bioactive delivery systems for tissue regeneration.Peptide/protein vaccine delivery system based on PLGA particles.The importance of interfaces in protein drug delivery - why is protein adsorption of interest in pharmaceutical formulations?Review physical and chemical aspects of stabilization of compounds in silk.Strategies for non-invasive delivery of biologics.Revolutionizing drug delivery through biodegradable multilayered particles.Biodegradable polymers as encapsulation materials for cosmetics and personal care markets.Novel drug delivery system: an immense hope for diabetics.Solid-state protein formulations.Combinatorial drug delivery approaches for immunomodulation.Extraction of PLGA-microencapsulated proteins using a two-immiscible liquid phases system containing surfactants.Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.Low molecular weight chitosan-insulin polyelectrolyte complex: characterization and stability studies.Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNAChitosan-HPMC-blended microspheres as a vaccine carrier for the delivery of tetanus toxoid.Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment.Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.Preparing Poly (Lactic-co-Glycolic Acid) (PLGA) Microspheres Containing Lysozyme-Zinc Precipitate Using a Modified Double Emulsion Method.Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide)."Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives".Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery.
P2860
Q30429889-EAC4FBCB-3551-4BF7-928E-2D29C20FCF63Q33290413-A4279333-BBD1-4114-994D-96CDEB050C91Q33563560-5EC9283C-E2D8-483A-A1DC-1106BCD0BD3EQ33604893-43D9F0AC-E229-4291-8FEB-42BD82C101EFQ34243142-7D292911-A39F-4379-BACC-A335E10072BEQ35533540-69D93E7E-2F22-4A6A-8ABD-2E1B1B8FA166Q36183987-C4D68AB8-B832-496E-9153-255ACC4E153FQ36316926-3F09CC8B-70D9-4272-B30E-7F70476ED468Q36359394-8E67CE53-B226-446C-9734-B1257275619DQ36500104-549FAF9C-532E-44AC-BFA4-047937544C7DQ36554910-146B2997-D243-4908-BF70-0CECA555026BQ36627231-68335AE4-7F70-4C54-8C5A-F7A5C249B85EQ36849488-E741A6E1-DC93-4CFC-B9A2-7A65D6800558Q36917923-DE084C35-2835-4C67-9A8D-0CFE13ACEF73Q37065943-91655EAD-037B-434B-BC4D-41A543CF8E5AQ37186189-7B925943-6F95-4E75-A45A-241F1298069AQ37612333-336B78B1-C30E-490A-82B7-6BFCF03D895AQ37777061-E7DD250A-8D39-489C-B569-8B9E9B9D8655Q37838652-3261AF48-C9B9-453D-BBBF-950D6E4EC9E9Q37873947-99787B71-7E1D-40F4-8835-47F33BC15D6AQ37978191-2435F0D5-5EF7-4470-9A7A-FA5E50964F4FQ38013190-FDBDC8A6-1642-495E-8170-7D67AE343A06Q38022059-53F90EDF-BC8C-4C20-A082-280B50B77DA1Q38052924-D580ED17-0F80-4833-ABCC-7ECB0F507062Q38302000-0FDB21B5-C1D9-41B4-9771-28CF768943C0Q38309879-48CF583C-8EF0-430E-8A0D-A42352D087E8Q38680602-5AC0AFFE-E5CA-4BAE-AD4F-0B42B899A735Q39248013-E911BF3B-BC0F-4519-9A09-373D8697A407Q39424203-C03EF78C-DEFA-4B7A-A025-9C5CA6B787D8Q40035573-9ACB546A-277A-414B-84DA-AE4737B5FEACQ41524170-CE8A7923-7771-4111-9EC5-7F7E15C02817Q41729731-6122E7A6-FCD7-40F6-87A0-5355312EB6F0Q41826178-474516B0-AEA8-44A2-B17E-E4140950C1CCQ41966521-BBC58C0C-FA85-4E29-9659-F8933F6AA503Q42378276-D4B64210-67EA-4AF4-B202-B2491016E0B2Q42906080-F21D791C-43FF-45D4-BFAC-6F57560A1591Q43287008-A2FF27D4-FF71-4A53-A4A5-570D4A173D73Q43492550-2B54065D-39E8-46B8-9FE9-5942B9E089B6Q44989827-896F214E-FC3D-44D1-B496-A6F9917E9D7EQ47701463-5C4537AF-B1EF-4905-ADF5-8AAC38FE8F39
P2860
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Strategic approaches for overc ...... able nano- and microparticles.
@ast
Strategic approaches for overc ...... able nano- and microparticles.
@en
type
label
Strategic approaches for overc ...... able nano- and microparticles.
@ast
Strategic approaches for overc ...... able nano- and microparticles.
@en
prefLabel
Strategic approaches for overc ...... able nano- and microparticles.
@ast
Strategic approaches for overc ...... able nano- and microparticles.
@en
P2093
P1476
Strategic approaches for overc ...... able nano- and microparticles.
@en
P2093
Eric Allémann
Eric Doelker
Ugo Bilati
P304
P356
10.1016/J.EJPB.2004.10.006
P407
P577
2005-04-01T00:00:00Z